Nexgel Inc (NXGL) Stock Price, Quote & News

Company Profile

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 215 702 8550

Website: nexgel.com

Address:

2150 Cabot Boulevard West, Suite B, Langhorne, United States

BigBoyTroy Jun. 24 at 10:36 PM

$NXGL Free discord link in my stoctwits Profile NXGL support and resistance levels $0.55 – $0.557 → current micro-support VWAP pivot $0.53 – $0.54 → next bounce zone if it dips $0.50 – $0.52 → major structural support $0.48 – $0.49 → breakdown floor last real safety net :red_circle: Resistance $0.58 – $0.60 $0.63 – $0.66 → major resistance wall (where prior momentum failed) $0.70 → trend breakout level needs real volume

0 · Reply

luckydog2 Jun. 24 at 4:30 PM

$NXGL Great product feedback...I love when a product works well! https://www.reddit.com/r/NXGL/s/0vSDKhzMx7

1 · Reply

LeverUp19 Jun. 24 at 3:23 PM

$NXGL Wonder if the higher volume combined with suppressed share price is the result of certain debt holders choosing to convert. Suppose it could also be some of the new salespeople buying in, but i would think that would be pushing the price up. Here's hoping Adam has got some good news for us in August. A reverse split would not be encouraging at this point.

0 · Reply

BigBoyTroy Jun. 24 at 11:29 AM

Free discord link in my stoctwits Profile my bullish 🐂 peeps if you are interested in joining IKT Resistance Zones $1.85 – $1.90 → $2.00 – $2.05 → $2.10 – $2.20 → $2.30+ $IKT $NXGL $HSCS $HURA

0 · Reply

LeverUp19 Jun. 22 at 2:02 PM

$NXGL Volume appears to have picked up quite a bit here over the last week or so.

0 · Reply

Ric_1M Jun. 21 at 2:45 PM

$TNON $SAGT $LFS $GDHG $NXGL "The key to making money in stocks is not to get scared out of them." Peter Lynch

0 · Reply

topstockalerts Jun. 19 at 11:52 PM

After Hours Top Gainers PT2 $AZTR $GDHG $ADTX $CTW $NXGL

1 · Reply

JLCw Jun. 19 at 9:36 PM

FINAL WATCHLIST $GPUS AI + crypto + robotics, needs 0.95 break $NXGL slow grind turnaround, needs confirmation $PULM merger story, timing-dependent $ACON fundamentals are strong, but need volume Have a great long weekend and happy Father's Day! - JL

1 · Reply

luckydog2 Jun. 19 at 1:10 PM

$NXGL Adam has set the company up for significant growth beyond hydrogel manufacturing. If you missed the June presentation, take a look at the transformation taking place. https://ir.stockpr.com/nexgel/sec-filings-email/content/0001493152-26-029100/ex99-1.htm

0 · Reply

topstockalerts Jun. 19 at 12:11 PM

After Hours Top Gainers PT2 $GDHG $ADTX $CTW $NXGL $SURG

0 · Reply

NEXGEL Slides: Investor presentation

Jun 17, 2026, 4:30 PM EDT - 7 days ago

NEXGEL Transcript: Planet MicroCap Las Vegas 2026

Jun 9, 2026, 8:00 AM EDT - 16 days ago

NEXGEL Proxy statement: Proxy filing

Jun 4, 2026, 9:00 AM EDT - 21 days ago

NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

NXGLW

May 29, 2026, 8:00 AM EDT - 27 days ago

NEXGEL Proxy statement: Proxy filing

2026-05-19T13:23:14.000Z - 5 weeks ago

NexGel announces data from institutional review board clinical study

May 19, 2026, 9:00 AM EDT - 5 weeks ago

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

NXGLW

May 15, 2026, 12:00 PM EDT - 5 weeks ago

NEXGEL Earnings Call Transcript: Q1 2026

May 15, 2026, 12:00 PM EDT - 5 weeks ago

NEXGEL Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 6 weeks ago

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NXGLW

May 12, 2026, 10:27 AM EDT - 6 weeks ago

NEXGEL To Report First Quarter 2026 Financial Results on May 15th

NXGLW

May 6, 2026, 9:00 AM EDT - 7 weeks ago

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NXGLW

2026-04-27T13:38:27.000Z - 2 months ago

NexGel appoints Ian Blackman as CFO

CELU

Apr 21, 2026, 4:30 PM EDT - 2 months ago

NEXGEL Transcript: M&A announcement

Apr 21, 2026, 4:30 PM EDT - 2 months ago

NEXGEL Press release: M&A announcement

2026-04-21T15:06:20.000Z - 2 months ago

NexGel closes acquisition of products from Celularity

CELU

Apr 17, 2026, 3:37 PM EDT - 2 months ago

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Apr 15, 2026, 4:12 PM EDT - 2 months ago

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 8, 2026, 4:05 PM EDT - 2 months ago

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

Mar 31, 2026, 4:12 PM EDT - 3 months ago

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

Mar 31, 2026, 7:00 AM EDT - 3 months ago

NEXGEL Annual report: Q4 2025

2026-03-12T13:15:47.000Z - 3 months ago

NexGel price target lowered to $2 from $6 at Maxim

2026-03-12T12:55:45.000Z - 3 months ago

NexGel announces terms of agreement of license for products from Celularity

CELU

Mar 12, 2026, 8:45 AM EDT - 3 months ago

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-03-12T12:35:15.000Z - 3 months ago

Celularity reiterates strategic commercialization partnership with NEXGEL

CELU

2026-03-10T12:51:55.000Z - 3 months ago

NexGel sign agreement to license, acquire portfolio of products from Celularity

CELU

Mar 10, 2026, 8:45 AM EDT - 3 months ago

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

2026-02-10T14:10:54.000Z - 4 months ago

NexGel announces financing of $1.797M relating to acquistion

2025-12-16T13:10:10.000Z - 6 months ago

NexGelRx receives additional investment from Eric Gruntfest, Ariel Imas

2025-12-11T13:15:18.000Z - 7 months ago

NexGel to spin-off drug delivery program into NexGelRx

Dec 11, 2025, 8:00 AM EST - 7 months ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

NEXGEL Earnings release: Q3 2025

Nov 11, 2025, 4:10 PM EST - 8 months ago

NEXGEL Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 8:00 AM EDT - 8 months ago

NEXGEL Proxy statement: Proxy Filing

Oct 20, 2025, 2:30 PM EDT - 8 months ago

NEXGEL Transcript: LD Micro Main Event XIX Investor Conference

Oct 20, 2025, 8:00 AM EDT - 8 months ago

NEXGEL Proxy statement: Proxy Filing

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 11 months ago

NEXGEL Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 11 months ago

NEXGEL Slides: Investor Presentation

Aug 6, 2025, 8:00 AM EDT - 11 months ago

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

2025-08-05T12:29:27.000Z - 11 months ago

NexGel appoints Steve Ciardiello to board of directors

SSTK

2025-08-01T12:05:29.000Z - 11 months ago

NexGel prices 413,044 shares at $2.30 in registered direct offering

Aug 1, 2025, 8:00 AM EDT - 11 months ago

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

2025-07-14T13:05:37.000Z - 1 year ago

NexGel, STADA announce expansion of partnership for North America

Jul 14, 2025, 9:00 AM EDT - 1 year ago

NEXGEL and STADA AG Announce Expansion of Partnership for North America

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings release: Q1 2025

May 9, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Apr 30, 2025, 8:00 AM EDT - 1 year ago

NEXGEL Proxy statement: Proxy Filing

Apr 23, 2025, 12:30 PM EDT - 1 year ago

NEXGEL Transcript: Planet MicroCap Showcase: VEGAS 2025

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q4 2024

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Annual report: Q4 2024

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings release: Q4 2024

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Feb 13, 2025, 9:00 AM EST - 1 year ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

2025-01-22T14:10:46.000Z - 1 year ago

NexGel expects to generate at least $13M in revenue in FY25

2025-01-22T14:05:27.000Z - 1 year ago

NexGel issues letter to shareholders

2025-01-22T14:05:10.000Z - 1 year ago

NexGel sees Q4 revenue approximately $3M

2025-01-02T14:05:24.000Z - 1 year ago

NexGel appoints McGuire as Chief Financial Officer

Jan 2, 2025, 9:00 AM EST - 1 year ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Dec 10, 2024, 10:30 AM EST - 1 year ago

NEXGEL Transcript: IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 2024

Nov 13, 2024, 4:40 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Earnings release: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Quarterly report: Q3 2024

2024-11-11T22:45:07.000Z - 1 year ago

NexGel announces $2M registered direct offering

Nov 11, 2024, 5:35 PM EST - 1 year ago

NEXGEL Announces $2,000,000 Registered Direct Offering

Oct 11, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Participate in Upcoming October Investor Conferences

2024-10-10T13:05:57.000Z - 1 year ago

NexGel expects Q3 revenue approx $2.85M

Oct 4, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings release: Q2 2024

Aug 14, 2024, 4:25 PM EDT - 2 years ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 12, 2024, 9:15 AM EDT - 2 years ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Jul 18, 2024, 9:15 AM EDT - 2 years ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 8, 2024, 4:05 PM EDT - 2 years ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jun 11, 2024, 8:40 AM EDT - 2 years ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

May 16, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Acquires International Beauty Brand, Silly George

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings release: Q1 2024

May 3, 2024, 8:00 AM EDT - 2 years ago

NEXGEL Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

NEXGEL Proxy statement: Proxy Filing

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Earnings release: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Annual report: Q4 2023

Apr 1, 2024, 7:50 AM EDT - 2 years ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 21, 2024, 9:00 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 12, 2024, 1:30 PM EDT - 2 years ago

NEXGEL Transcript: iAccess Alpha Best Ideas Spring Virtual Conference

Mar 4, 2024, 8:30 AM EST - 2 years ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Jan 9, 2024, 8:30 AM EST - 2 years ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Dec 11, 2023, 8:00 AM EST - 2 years ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Earnings Call Transcript: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Quarterly report: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Earnings release: Q3 2023

Nov 13, 2023, 4:05 PM EST - 2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Sep 26, 2023, 9:49 AM EDT - 2 years ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Quarterly report: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q2 2023

Aug 2, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Jul 19, 2023, 9:10 AM EDT - 3 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jun 15, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

May 26, 2023, 8:00 AM EDT - 3 years ago

NEXGEL Registration statement: Registration Filing

May 24, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Quarterly report: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q1 2023

May 9, 2023, 9:15 AM EDT - 3 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

Apr 27, 2023, 8:00 AM EDT - 3 years ago

NEXGEL Proxy statement: Proxy Filing

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q4 2022

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings release: Q4 2022

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Annual report: Q4 2022

Mar 27, 2023, 4:05 PM EDT - 3 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 15, 2023, 7:30 AM EDT - 3 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 7, 2023, 7:30 AM EST - 3 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 2, 2023, 8:30 AM EST - 3 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Jan 17, 2023, 7:30 AM EST - 3 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Dec 8, 2022, 7:30 AM EST - 3 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

BigBoyTroy Jun. 24 at 10:36 PM

0 · Reply

luckydog2 Jun. 24 at 4:30 PM

$NXGL Great product feedback...I love when a product works well! https://www.reddit.com/r/NXGL/s/0vSDKhzMx7

1 · Reply

LeverUp19 Jun. 24 at 3:23 PM

0 · Reply

BigBoyTroy Jun. 24 at 11:29 AM

0 · Reply

LeverUp19 Jun. 22 at 2:02 PM

$NXGL Volume appears to have picked up quite a bit here over the last week or so.

0 · Reply

Ric_1M Jun. 21 at 2:45 PM

$TNON $SAGT $LFS $GDHG $NXGL "The key to making money in stocks is not to get scared out of them." Peter Lynch

0 · Reply

topstockalerts Jun. 19 at 11:52 PM

After Hours Top Gainers PT2 $AZTR $GDHG $ADTX $CTW $NXGL

1 · Reply

JLCw Jun. 19 at 9:36 PM

1 · Reply

luckydog2 Jun. 19 at 1:10 PM

0 · Reply

topstockalerts Jun. 19 at 12:11 PM

After Hours Top Gainers PT2 $GDHG $ADTX $CTW $NXGL $SURG

0 · Reply

topstockalerts Jun. 19 at 12:51 AM

After Hours Top Gainers PT2 $AZTR $GDHG $ADTX $CTW $NXGL

0 · Reply

Luka_Brasi Jun. 18 at 4:50 PM

$NXGL Doesn't look like the poster presentation was well received. Maybe there's no market for water jelly? Alcohol and flavors are the way to go I believe.

0 · Reply

OldManLogan Jun. 18 at 1:30 PM

$NXGL 100%, you are now invested in an Ebita-positive regenerative medicine company with a slice of hydrogels on the side now... and there could also be synergies between the two... Adam feels they can now get silverseal into hospitals, for example...

0 · Reply

Nightwolf6502 Jun. 18 at 7:07 AM

$NXGL It's pretty obvious after watching the presentation from yesterday that this is no longer a hydrogel company. So glad I've been buying in so cheap. Really looking forward to seeing where they are at the end of the year, especially with all these new products they have in the pipeline right now.

1 · Reply

topstockalerts Jun. 17 at 11:03 PM

$NXGL this one earned a closer look today

0 · Reply

LeverUp19 Jun. 17 at 5:05 PM

$NXGL Big volume spike!

0 · Reply

LeverUp19 Jun. 17 at 3:19 PM

$NXGL Volume picking up a bit today heading into the presentation.

0 · Reply

Luka_Brasi Jun. 17 at 9:27 AM

$NXGL Maybe they could add alcohol to the water jelly for an adult experience. Diet Air in the pipeline.

1 · Reply

OldManLogan Jun. 16 at 3:32 PM

$NXGL Let's hear what Adam has to say tomorrow. I'm sure it's very busy integrating the new assets, but he's got to get the story out there.

1 · Reply

Luka_Brasi Jun. 11 at 7:21 PM

$NXGL It's summer time, good time for frozen water jelly.

0 · Reply

Luka_Brasi Jun. 11 at 7:20 PM

$NXGL Isn't this the one who's lab and production facility is a small section of a multi tenant warehouse and has a handful of employees? I think it was actually more exec's than employees, never a good sign.

0 · Reply

OldManLogan Jun. 11 at 6:23 PM

$NXGL Strange trading today...

1 · Reply

Market Cap	5.15M
Revenue (ttm)	11.42M
Net Income (ttm)	-3.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-26.27%
Debt to Equity Ratio	0.00

Volume	973,100
Avg Vol	371,608
Day's Range	N/A - N/A
Shares Out	9.23M
Stochastic %K	12%
Beta	0.74
Analysts	Strong Sell
Price Target	$2.00